LIPO
Lipella Pharmaceuticals
LIPO
LIPO
Delisted
LIPO was delisted on the 18th of June, 2025.
5 hedge funds and large institutions have $39.7K invested in Lipella Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
Holders
5
Holders Change
-2
Holders Change %
-28.57%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
HF
1
HRT Financial
New York
|
$8K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $16.3K | 34,520 | – | – |
|
2
Geode Capital Management
Boston,
Massachusetts
| $11.8K | 24,915 | -1,083 | -4% |
|
|
HF
3
HRT Financial
New York
| $8K | 17,619 | +17,619 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $3.63K | 7,694 | -24 | -0.3% |
|
5
Bank of America
Charlotte,
North Carolina
| $22 | 47 | +1 | +2% |
|
|
SM
6
Sabby Management
Miami Beach,
Florida
| – | – | -540,250 | Closed |
|
7
Two Sigma Investments
New York
| – | – | -12,984 | Closed |
|
8
UBS Group
Zurich,
Switzerland
| – | – | -8,775 | Closed |
|
|
CFGS
9
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|